This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Media Center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Marketing & Communications:
Lindsay Bosslet, MPH

Phone: 206.285.3500

Fax: 206.285.6619

Email: media@path.org

Recent Press Coverage

  1. Vaccines are among modern medicine’s greatest innovations, allowing billions of people to lead healthy lives. But stopping outbreaks of vaccine-preventable disease – and not only COVID-19 – depends on achieving critical mass with immunization campaigns.
    Published: August 2021
  2. A recent drop in South Africa’s COVID-19 cases offered a glimmer of hope as NPR tracked spikes in other countries including Algeria, Mozambique, and Namibia. PATH’s oxygen needs tracker added nuance to the analysis, as 13 countries’ needs surged.
    Published: July 2021
  3. Why don’t we have more thermostable, easy-to-administer vaccines?
    Published: June 2021
  4. Our tests will need frequent touch-ups to make sure that no mutations get past them.
    Published: June 2021
Load more

PATH Newsroom

857 Items
857 Items
857 Items
    Date
  1. Published: December 2021
    Type: Press Release
  2. A century after the discovery of insulin, millions of people living with diabetes cannot obtain or afford the necessary supplies to self-manage their diabetes on a day-to-day basis. PATH partners with the Helmsley Charitable Trust to improve access to diabetes self-care in Mali, Mozambique, and Tanzania.
    Published: November 2021
    Type: Press Release
  3. Global convening of syringe manufacturers and multilateral organizations held to help bolster supply.
    Published: November 2021
    Type: Press Release
  4. Routine childhood immunization with pneumococcal vaccines is a critical step in India's fight against pneumonia and other pneumococcal diseases.
    Published: November 2021
    Type: Statement
  5. New high-quality and affordable serotype-specific monoclonal antibodies (mAbs) now globally available to support vaccine manufacturers in the development of pneumococcal vaccines
    Published: November 2021
    Type: Press Release
Load more